Thongsukmak; Atsawin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thongsukmak; Atsawin.The latest application filed is for "delayed release methylphenidate compositions".

Company Profile

9.11.16

Thongsukmak; Atsawin - Basking Ridge NJ
Thongsukmak; Atsawin - Piscataway NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Programmable pharmaceutical compositions for chrono drug release Grant 11,439,585 - Vaka , et al. September 13, 2	2022-09-13
Programmable pharmaceutical compositions for chrono drug release Grant 11,419,813 - Vaka , et al. August 23, 2	2022-08-23
Delayed Release Methylphenidate Compositions App 20220133635 - Vaka; Siva Ram Kiran ; et al.	2022-05-05
Programmable Pharmaceutical Compositions For Chrono Drug Release App 20220096366 - Vaka; Siva Ram Kiran ; et al.	2022-03-31
Delayed Release Methylphenidate Compositions App 20220040114 - Vaka; Siva Ram Kiran ; et al.	2022-02-10
Programmable Pharmaceutical Compositions For Chrono Drug Release App 20210393512 - Vaka; Siva Ram Kiran ; et al.	2021-12-23
Programmable pharmaceutical compositions for chrono drug release Grant 11,166,906 - Vaka , et al. November 9, 2	2021-11-09
Programmable pharmaceutical compositions for chrono drug release Grant 11,154,494 - Vaka , et al. October 26, 2	2021-10-26
Programmable Pharmaceutical Compositions For Chrono Drug Release App 20210228474 - Vaka; Siva Ram Kiran ; et al.	2021-07-29
Programmable Pharmaceutical Compositions For Chrono Drug Release App 20210205207 - Vaka; Siva Ram Kiran ; et al.	2021-07-08
Programmable pharmaceutical compositions for chrono drug release Grant 11,000,471 - Vaka , et al. May 11, 2	2021-05-11
Programmable pharmaceutical compositions for chrono drug release Grant 10,980,738 - Vaka , et al. April 20, 2	2021-04-20
Opioid agonist / antagonist combination dosage forms Grant 10,960,001 - Shah , et al. March 30, 2	2021-03-30
Programmable Pharmaceutical Compositions For Chrono Drug Release App 20210030685 - Vaka; Siva Ram Kiran ; et al.	2021-02-04
Programmable pharmaceutical compositions for chrono drug release Grant 10,898,431 - Vaka , et al. January 26, 2	2021-01-26
Programmable Pharmaceutical Compositions For Chrono Drug Release App 20200405626 - Vaka; Siva Ram Kiran ; et al.	2020-12-31
Programmable Pharmaceutical Compositions For Chrono Drug Release App 20200253861 - Kind Code	2020-08-13
Abuse-resistant drug formulations with built-in overdose protection Grant 10,632,113 - Vaka , et al.	2020-04-28
Supersaturated stabilized nanoparticles for poorly soluble drugs Grant 10,500,282 - Desai , et al. Dec	2019-12-10
Opioid Agonist / Antagonist Combination Dosage Forms App 20190358221 - Shah; Navnit H. ; et al.	2019-11-28
Extended Release Drug Formulation With Overdose Protection And Abuse Deterrence App 20190282508 - Shah; Navnit H. ; et al.	2019-09-19
Surfactant-free Hiv Protease Inhibitor Composition And Method Of Manufacturing Thereof App 20190030006 - Shah; Navnit H. ; et al.	2019-01-31
Food Independent Immediate Release Drug Formulation With Abuse Deterrence And Overdose Protection App 20180296486 - Shah; Navnit H. ; et al.	2018-10-18
Surfactant-free HIV protease inhibitor composition and method of manufacturing thereof Grant 10,034,865 - Shah , et al. July 31, 2	2018-07-31
Surfactant-free Hiv Protease Inhibitor Composition And Method Of Manufacturing Thereof App 20170071915 - SHAH; NAVNIT H. ; et al.	2017-03-16
Supersaturated Stabilized Nanoparticles For Poorly Soluble Drugs App 20150335753 - Desai; Dipen ; et al.	2015-11-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.